Pfizer, Inc. Share Price

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 01:30:30 15/06/2024 am IST After market 03:01:17 am
27.53 USD -0.43% Intraday chart for Pfizer, Inc. 27.51 -0.07%
Sales 2024 * 60.51B 5,054B Sales 2025 * 62.72B 5,239B Capitalization 157B 13,087B
Net income 2024 * 6.88B 575B Net income 2025 * 10.51B 878B EV / Sales 2024 * 3.57 x
Net Debt 2024 * 59.14B 4,940B Net Debt 2025 * 54.22B 4,529B EV / Sales 2025 * 3.36 x
P/E ratio 2024 *
21 x
P/E ratio 2025 *
14.2 x
Employees 88,000
Yield 2024 *
6.04%
Yield 2025 *
6.16%
Free-Float 59.05%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.51%
1 week-3.67%
Current month-3.94%
1 month-3.00%
3 months-2.13%
6 months+5.36%
Current year-4.38%
More quotes
1 week
27.20
Extreme 27.2
28.35
1 month
27.20
Extreme 27.2
29.73
Current year
25.20
Extreme 25.2
30.28
1 year
25.20
Extreme 25.2
40.36
3 years
25.20
Extreme 25.2
61.71
5 years
25.20
Extreme 25.2
61.71
10 years
25.20
Extreme 25.2
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 01/93/01
Director of Finance/CFO 59 02/22/02
Chief Tech/Sci/R&D Officer - 01/19/01
Members of the board TitleAgeSince
Director/Board Member 66 01/20/01
Director/Board Member 64 23/17/23
Director/Board Member 60 27/13/27
More insiders
Date Price Change Volume
15/24/15 27.53 -0.43% 28 133 939
13/24/13 27.65 -0.04% 33,945,218
12/24/12 27.66 -1.32% 32,507,942
11/24/11 28.03 -0.14% 29,573,536
10/24/10 28.07 -1.78% 37,003,192

Delayed Quote Nyse, June 15, 2024 at 01:30 am IST

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.65 USD
Average target price
31.92 USD
Spread / Average Target
+15.43%
Consensus